Table 4. Predictors for adverse clinical events (combined hazard endpoint).
| OR (95% CI) | P value | |
| CABG: coronary artery bypass grafting; LAAC: left atrial appendage closure; PCI: percutaneous coronary intervention. | ||
| Age at LAAC | 1.04 (1.01−1.06) | 0.01 |
| Female | 1.03 (0.68−1.58) | 0.88 |
| Body mass index | 0.99 (0.96−1.01) | 0.64 |
| Diabetes mellitus | 1.20 (0.78−1.84) | 0.40 |
| Arterial hypertension | 1.38 (0.72−2.79) | 0.36 |
| Coronary artery disease | 1.21 (0.57−2.48) | 0.61 |
| Prior PCI/CABG | 0.84 (0.42−1.75) | 0.64 |
| Congestive heart failure | 2.09 (1.25−3.49) | 0.01 |
| Glomerular filtration rate | 0.99 (0.90−1.0) | 0.10 |
| Kidney disease | 0.88 (0.46−1.66) | 0.70 |
| Liver disease | 1.18 (0.54−2.53) | 0.67 |
| CHA2DS2-VASc score | 1.01 (0.83−1.23) | 0.94 |
| HAS-BLED score | 1.29 (0.99−1.67) | 0.06 |